Scarlet Therapeutics Limited (13536278) is a private limited with share capital incorporated on 28/07/2021 (4 years old) and registered in bristol, BS20JZ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Scarlet therapeutics is developing a unique platform that generates novel red blood cell-based therapeutics to potentially treat a wide range of diseases. initially targeted at the rare metabolic diseases, hyperammonemia and hyperoxaluria, this approach could also be used more broadly to target othe...
Termination Director Company With Name Termination Date
Category:Officers
Date:19-05-2026
Termination Director Company With Name Termination Date
Category:Officers
Date:19-05-2026
Capital Allotment Shares
Category:Capital
Date:30-04-2026
Capital Allotment Shares
Category:Capital
Date:24-04-2026
Capital Allotment Shares
Category:Capital
Date:24-04-2026
Capital Allotment Shares
Category:Capital
Date:17-04-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:17-04-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:13-04-2026
Memorandum Articles
Category:Incorporation
Date:03-04-2026
Resolution
Category:Resolution
Date:03-04-2026
Resolution
Category:Resolution
Date:17-03-2026
Capital Allotment Shares
Category:Capital
Date:14-02-2026
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:14-08-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:06-08-2025
Resolution
Category:Resolution
Date:25-11-2024
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:20-11-2024
Capital Allotment Shares
Category:Capital
Date:15-11-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-08-2024
Change Person Director Company With Change Date
Category:Officers
Date:02-08-2024
Resolution
Category:Resolution
Date:24-06-2024
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:24-06-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:24-06-2024
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:15-03-2024
Withdrawal Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:03-10-2023
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:03-10-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:03-10-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:02-10-2023
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:29-09-2023
Capital Allotment Shares
Category:Capital
Date:27-09-2023
Capital Allotment Shares
Category:Capital
Date:27-09-2023
Confirmation Statement
Category:Confirmation Statement
Date:08-08-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:04-08-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:04-08-2023
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:24-04-2023
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:16-01-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:21-12-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:21-12-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:21-12-2022
Resolution
Category:Resolution
Date:22-08-2022
Memorandum Articles
Category:Incorporation
Date:22-08-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:17-08-2022
Capital Allotment Shares
Category:Capital
Date:17-08-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:02-08-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:01-08-2022
Resolution
Category:Resolution
Date:20-07-2022
Capital Alter Shares Subdivision
Category:Capital
Date:20-07-2022
Capital Allotment Shares
Category:Capital
Date:15-07-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:14-07-2022
Incorporation Company
Category:Incorporation
Date:28-07-2021
Innovate Grants
2
This company received a grant of £332036.02 for Univercell: An Engineered Red Blood Cell Line To Unlock A New, Universal Therapeutic Modality. The project started on 01/09/2023 and ended on 28/02/2025.
This company received a grant of £587680.0 for Bioengineered Reticulocytes Containing Metabolic Enzymes To Treat Hyperammonemia And Hyperoxaluria. The project started on 01/05/2024 and ended on 31/01/2026.